Published • loading... • Updated
The Economy of Appetite: the Size of the Impact of GLP-1 in Brazil
Summary by braziljournal.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The pharmaceutical retail sold R$ 255 billion in the 12 months until April – an annual discharge of 11.7%. GLP-1-based drugs responded by 85% of this growth: without them, expansion would have remained at 8.6%. The data are from IQVIA, a health research company, and were presented during an event that Pay Less and Itaú BBA organized yesterday in São Paulo to discuss the impacts and potential of GLP-1 in different industries – especially after th…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
